SureTrader Nadex Advertisement PGUS
Home > Boards > US OTC > Miscellaneous >

EP Global Communications, Inc. (EPGL)

EPGL RSS Feed
Add EPGL Price Alert      Hide Sticky   Hide Intro
Moderator: Atlanta1, flaflyersfan, integral, Stock Barber, vikingzskillz, Hyd
Search This Board: 
Last Post: 3/25/2017 4:10:28 AM - Followers: 476 - Board type: Free - Posts Today: 8

 EPGL  


People, Products & Process:
EPGL has assembled an impressive team to propel the company into a bright future and to build shareholder value. Under the leadership of Michael Hayes EPGL underwent debt restructuring, assembly of a new management team, as well as medical and scientific personnel. Mr. Hayes has made it a singular priority to bring aboard only the world’s top professionals in the field of medical sciences to EPGL and thereby build the Company into a major player in the Medical Device Industry over the next several years. He has also committed to prioritizing shareholders and creating significant value for their investment over time. We have seen great evidence of the har work over the last couple years as EPGL has signed Development Agreements with CooperVision, Intel, and AT&T. EPGL is in negotiations to licence technology to CooperVision presently. On April 28th 2015, EPGL disclosed to shareholders that
EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties. Shareholders can expect developments on this in the near future.


One key team member that was brought on board is David Markus (Vice President, BioMEMS) Developer, As you will see David Markus is a Well Accomplished Engineer.

David T. Markus holds a Ph.D. in Biomedical Engineering and a MS in Electrical Engineering with an emphasis in MEMS Microelectronics and Biomedical. Dr. Markus spent 11 years with Raytheon and holds 8 US patents and has 9 other US Patents Pending. He has been involved in research for several of the world's leading technological institutions, including the Office of Naval Research in Arlington, Virginia, NASA Jet Propulsion Laboratory in Pasadena, CA and he has been published 15 times for various technical conferences. He was a principal investigator on SBIR DARPA Phase I and Phase II, and "Ultraflexible Substrate" for Macroelectronics Program by Dr. Robert Reuss at DARPA. He has been involved in the engineering and the development on seven surgical devices, including devices for Cataract surgery, Intra-Ocular Lens Delivery, Arthroscopy, Endodontic Endoscope, Micro Endoscope and Neural Electrodes. Additionally he was instrumental on developing three medical laboratory devices, including for In-Vitro Fertilization, PCR instrumentation and drug discovery.

The Company claims to have significant know-how and Intellectual Property in the arena of BioMEMS and claims to have invented new device technologies which include, but are not limited to the following:
 
1. Advanced Power Source for Contact Lenses 11. Advanced TopSpin Platform Technology for Development of Smart Medical Devices
2. Advanced Cell Regeneration Technology to Treat Eye Disease 12. Advanced Device for Steam Cell Treatment Delivery
3. Advanced Cell Regeneration Technology to Treat Hearing Loss 13. Advanced Device for Treatment of Prostate Tumors
4. Advanced Nerve Ablation Device 14. Advanced Endoscopic Device
5. Advanced Epidural Device 15. Advanced Device for Delievery of Micron Sized Drug Payloads
6. New & Promsing Treatment of Restinitis Pigmentosa 16. New & Promising Device for Treatment of Macular Degeneration
7. Advanced Ablation Device for Nerve Treatment of Facial Glabballar Frownig 17. New Advanced Contact Lens Device
8. New Advanced PowerSource for TopSpin Medical Devices 18. Advanced Device For Delivery of Micro Mechanical Devices Into Body
9. Advanced Trigger Point Needle Device 19.  Device for  Advanced Biopsy
10. Advanced Micron Resolution Motor for Smart Medical Devices 20. Real-Time Sensor Technologies for Connectivity to a Global Network  **NEW
21.Real-Time Data Applications for Athletic Teams, Workforces and Military Forces*NEW
 


About EPGL Medical Science's Share Structure :

EPGL has a share structure of 5 billion authorized shares with approximately 4.5 billion shares restricted and a float of approximately 499 million. Following a very successful Reverse Split EPGL has decreased the float by 90% and increased share holder value by over 500% since that time. The company has strongly stated many times that they will not sell shares into the retail market. They are here to build a real company and implement real growth. Since restructuring EPGL has not increased the Float/OS/AS and have given us there word on countless occasions they will not do so.

Pricewaterhouse Coopers, Corporate Finance and Recovery (Cayman) Ltd.Controlling Agent for:
AJW Qualified Partners, LLC, Controlled by PwC (PricewaterhouseCoopers) - Court appointed
1.975 Billion Common Shares
Mr. Michael Hayes
1.975 Billion Common Shares
FLOAT/TRADABLE SHARES : 499 Million ***Unchanged since Restructure in 2012***
Total number of shareholders of record 700 approximate 

ISSUERS FACILITIES
The Company claims to have leases or utilizes facilities in the following locations

Various California Bay Area Research Facilities Under NDA, David T. Markus, Ph.D.

Irvine, California – Research Facilities, Office

New York University Langone Medical Center, Corey W. Hunter M.D. / Eric Lee M.D.

University of Minnesota, David T. Markus, Ph.D.

University of California at Irvine, David T. Markus, Ph.D.

Dallas and Plano Texas, David T. Markus, Ph.D. **NEW**


Follow EPGL on the WEB at http://www.epglmed.com







 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
EPGL
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PostSubject
#108787  Sticky Note EPGL Wins Allowance on First Patent vikingzskillz 08/30/16 10:08:17 PM
#95482  Sticky Note Press releases or other company communication should not IH Brian (Retired) 01/12/16 12:14:18 PM
#117208   MM's do not manipulate pinks H8ster 03/25/17 04:10:27 AM
#117207   $EPGL Update: 105+ people on a Friday night vikingzskillz 03/25/17 02:03:52 AM
#117206   When you have Multi billion dollar companies co-filling vikingzskillz 03/25/17 02:01:32 AM
#117205   Main point tonight is to address slight delay vikingzskillz 03/25/17 01:50:51 AM
#117204   EPGL Energy Harvester Patent Coming, more in pipeline... vikingzskillz 03/25/17 01:36:08 AM
#117203   "Things could happen any day as far as vikingzskillz 03/25/17 01:30:21 AM
#117202   LOL! MM's do not manipulate pinks... they Stock Barber 03/25/17 12:20:56 AM
#117201   There are no retail short sellers in EPGL. H8ster 03/25/17 12:07:56 AM
#117200   http://www.goldmansachs.com/our-thinking/pages/virtual-and-augmented-reality.htm GS1 03/24/17 11:41:29 PM
#117199   EPGL weekly BB chart jhnvtjll 03/24/17 11:35:27 PM
#117198   Lord I hope no longs here believe that Stock Barber 03/24/17 11:06:13 PM
#117197   I don't know who is shorters, but what kura 03/24/17 10:48:49 PM
#117195   Absolutely, and last desperate effort of the Shorters ComeWhatMay 03/24/17 09:48:59 PM
#117194   no. it was his typical, stammering, carrot-filled blather Atlanta1 03/24/17 09:48:30 PM
#117193   Did he say anything new and interesting? kura 03/24/17 09:39:46 PM
#117192   Somebody walked into their brokers office and dropped wobblenuts 03/24/17 09:11:14 PM
#117191   The truth is Hayes and EPGL are in skorz 03/24/17 09:08:33 PM
#117189   We will see in due time won't we? ComeWhatMay 03/24/17 07:57:06 PM
#117188   I hope these geniuses run this down some ComeWhatMay 03/24/17 07:55:48 PM
#117187   Almost amusing to hear the lies and non KBing617 03/24/17 07:52:16 PM
#117186   Hahahahahaha H8ster 03/24/17 07:50:39 PM
#117183   wow - what a waste of 45 minutes..... Atlanta1 03/24/17 07:49:10 PM
#117182   Same amount of sales, that's how it works KBing617 03/24/17 07:42:27 PM
#117181   Same conference call as always and stock will KBing617 03/24/17 07:41:34 PM
#117180   100M jhnvtjll 03/24/17 07:40:57 PM
#117179   did he just say InWith has 100 billion shares? Atlanta1 03/24/17 07:39:33 PM
#117178   nothing but carrot babble.... Atlanta1 03/24/17 07:38:49 PM
#117177   Technical difficulties earlier. jhnvtjll 03/24/17 07:27:02 PM
#117176   Sure is, they know it and planned for KBing617 03/24/17 07:26:35 PM
#117175   Ohhh those guys, they say a lot of KBing617 03/24/17 07:24:06 PM
#117174   this is freaking hilarious. Atlanta1 03/24/17 07:21:30 PM
#117173   really Mikey - are you serious? Atlanta1 03/24/17 07:21:04 PM
#117172   2 minutes has now turned into 20... Atlanta1 03/24/17 07:19:30 PM
#117169   something seems just a bit fishy here, guys.... Atlanta1 03/24/17 07:18:32 PM
#117168   Mikey - are you headed to mexico? Atlanta1 03/24/17 07:17:40 PM
#117167   Live conference call to stop the bleeding of KBing617 03/24/17 07:16:46 PM
#117166   is this some kind of joke, Mikey??? Atlanta1 03/24/17 07:15:59 PM
#117165   somebody make sure to burp Mikey before he Atlanta1 03/24/17 07:15:09 PM
#117164   hello - McFly? Atlanta1 03/24/17 07:13:38 PM
#117163   You're welcome. Go EPGL! jhnvtjll 03/24/17 07:12:32 PM
#117162   Maybe he bumped into a hot sorority girl jhnvtjll 03/24/17 07:12:08 PM
#117161   Thanks Squeejo 03/24/17 07:10:57 PM
#117160   looks like two minutes is turning into 10. Atlanta1 03/24/17 07:10:31 PM
#117159   Hayes came on earlier and said he'll be jhnvtjll 03/24/17 07:10:10 PM
#117158   Are you hearing anything on the CC . Squeejo 03/24/17 07:09:26 PM
#117157   Still strong if you look at the multi-year jhnvtjll 03/24/17 07:07:41 PM
#117156   the stock was down 14% for the day, Atlanta1 03/24/17 07:06:11 PM
#117155   the stock was down 14% for the day, Atlanta1 03/24/17 07:06:10 PM
#117154   Look at the print, more shares were bought jsolo1 03/24/17 07:04:21 PM
#117153   CC starts in 2 minutes according to Hayes. jhnvtjll 03/24/17 07:03:01 PM
PostSubject